Tatva Chintan Pharma Chem Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹1110(102.49%)
Premium (ELP)
Tatva Chintan Pharma Chem Limited's successfully completed its Initial Public Offering and commenced trading on Jul 29, 2021 at the NSE, BSE exchange. The company raised 46,16,804 Shares through this public offering, comprising 20,77,562 Shares in fresh capital and ₹275.00 Cr through the Offer for Sale mechanism.
The IPO was priced within the band of ₹1,073 to ₹1,083, with minimum application lots of 13 shares. The offering attracted significant investor interest during its subscription period from Jul 16, 2021 to Jul 20, 2021.
Share allotment was finalized on Jul 26, 2021, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer engaged in producing structure directing agents, phase transfer catalysts, pharmaceutical and agrochemical intermediates, and other specialty chemicals, and is among the largest producers of SDAs for zeolites in India. The company caters to a wide range of industries including automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceuticals, personal care, and others, with products sold in India and exported to over 25 countries such as the USA, Germany, South Africa, China, and the UK. Exports contributed around 76% of its revenue in FY 2020, and its customer base includes leading names like Merck, Bayer AG, Laurus Labs, Navin Fluorine, Atul Limited, SRF Limited, and Divi’s Laboratories, with manufacturing facilities located at Ankleshwar and Dahej in Gujarat.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Leading Manufacturer: Specializes in structure directing agents and phase transfer catalysts.
- Diversified Portfolio: Offers a wide range of products.
- Global Presence: Serves customers across industries worldwide.
- Strategic Location: Gujarat facility near Hazira Port for easy logistics.
- Experienced Leadership: Promoters supported by a skilled management team.
- Strong Financials: Consistent track record of solid financial performance.
NA
- Ajaykumar Mansukhalal Patel
- Chintan Nitinkumar Shah
- Shekhar Rasiklal Somani
Tatva Chintan Pharma Chem Limited
Link Intime India Private Limited